Chemed Reports Second-Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Chemed Corporation (CHE) Tops Q2 EPS by 12c
July 23, 2015 4:48 PM EDTChemed Corporation (NYSE: CHE) reported Q2 EPS of $1.71, $0.12 better than the analyst estimate of $1.59. Revenue for the quarter came in at $382 million versus the consensus estimate of $373.61 million.
Chemed Corporation sees FY2015 EPS of $6.60-$6.75, versus the consensus of $6.64.
Full Guidance for... More
